Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
SURMOUNT examined tirzepatide for weight management (NEJM, 2022)
The medications unique power lies in its ability to mimic the GLP-1 hormone, which effectively modulates key hunger and satiety signals in the brain and slows gastric emptying, leading to a sustainable reduction in caloric intake
Tirzepatide, the newest dual GLP-1/GIP receptor agonist, has a similar 5-day half-life, but limited data suggest potentially less gastric emptying delay compared to pure GLP-1 agonists due to dual receptor activation [30]
Insert one suppository and retain for 15-30 minutes if possible
Membership can be canceled any time with 30 days notice
US$ 29.11
US$ 24.63
US$ 25.58
